BI Asset Management Fondsmaeglerselskab’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.14M | Buy |
306,506
+264,002
| +621% | +$4.42M | 0.05% | 251 |
|
|
2025
Q1 | $653K | Sell |
42,504
-230,130
| -84% | -$3.54M | 0.01% | 525 |
|
|
2024
Q4 | $6.01M | Buy |
+272,634
| New | +$6.01M | 0.06% | 210 |
|
|
2024
Q2 | – | Sell |
-6,609
| Closed | -$93K | – | 737 |
|
|
2024
Q1 | $93K | Buy |
+6,609
| New | +$93K | ﹤0.01% | 675 |
|
|
2020
Q4 | – | Sell |
-2,023
| Closed | -$18K | – | 477 |
|
|
2020
Q3 | $18K | Buy |
+2,023
| New | +$18K | ﹤0.01% | 456 |
|